Dear Arty,Induced pluripotent stem cell therapies pose...

Dear Arty,

Induced pluripotent stem cell therapies pose significant unique challenges with respect to safety, potency, genetic stability, immunogenicity, tumorgenicity, cell reproducibility and scalability.

You have shown yourself to be a hater of first responders and made comments about my family.

I try to keep it civil and report what I see and read and I genuinely feel that CYP is a decade away at a minimum if it survives.

Nobody here will agree as they are invested and can't sell out as it isn't a stock that trades being a penny hopefull.

There is a decade to go before IPSC's are on the commercial books, if ever.